Mannheim, Germany

Baerbel Stieren

This inventor holds 1 USPTO granted patent. Top assignee: Knoll Aktiengesellschaft. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Baerbel Stieren. Retrieved from https://idiyas.com/inventor/baerbel-stieren

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Baerbel Stieren: Innovator in Sustained Release Tablet Technology

Introduction

Baerbel Stieren is a notable inventor based in Mannheim, Germany. She has made significant contributions to the field of pharmaceutical technology, particularly in the development of sustained release tablets. Her innovative work has led to the creation of a unique formulation that enhances drug delivery systems.

Latest Patents

Baerbel Stieren holds 1 patent for her invention titled "Sustained release tablet of a mixture of alginates and polyacrylates." This patent describes a mixture of alginate and polyacrylate in a specific ratio, which is suitable for the preparation of depot drug forms. This advancement has the potential to improve the efficacy and efficiency of drug administration.

Career Highlights

Stieren is associated with Knoll Aktiengesellschaft, a prominent company in the pharmaceutical industry. Her work at Knoll has allowed her to focus on innovative drug delivery systems, contributing to the company's reputation for excellence in pharmaceutical research and development.

Collaborations

Throughout her career, Baerbel has collaborated with esteemed colleagues such as Heinz Einig and Matthias Hollmann. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Baerbel Stieren's contributions to sustained release tablet technology exemplify her dedication to advancing pharmaceutical science. Her innovative patent and collaborative efforts highlight her role as a key figure in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…